OverviewChartTechnicalNews
Derivatives
TraderScreen

Zai Lab Ltd/  US98887Q1040  /

NASDAQ
15/07/2024  22:00:00 Chg. -0.0400 Volume Bid12:00:18 Ask12:00:18 High Low
18.0000USD -0.22% 455,821
Turnover: 6.28 mill.		 17.9200Bid Size: 100 19.2000Ask Size: 100 18.2300 17.5450
GlobeNewswire 01/06 Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...
GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 18/04 Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire 10/04 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 06/03 Crescendo Biologics to present at the 2024 AACR Annual Meeting
GlobeNewswire 05/03 Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of...
GlobeNewswire 29/02 argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire 14/02 Genmab Publishes 2023 Annual Report
GlobeNewswire 16/01 Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire 08/01 argenx Highlights 2024 Strategic Priorities
GlobeNewswire 04/01 Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
GlobeNewswire 13/12/2023 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire 06/12/2023 Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307...
GlobeNewswire 07/11/2023 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 31/10/2023 argenx Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 26/10/2023 Zai Lab Announces Participation in November Investor Conferences
GlobeNewswire 18/10/2023 Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire 05/10/2023 Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023
GlobeNewswire 21/09/2023 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire 18/09/2023 Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and No...
GlobeNewswire 18/09/2023 Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injec...
GlobeNewswire 12/09/2023 Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockh...
GlobeNewswire 07/09/2023 Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR...
GlobeNewswire 04/09/2023 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 30/08/2023 Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patien...